Medical Cannabis Treatment for Autism to Begin Clinical Trials
There is a lot of anecdotal evidence that suggests that cannabis can treat autism, but there’s little research to back it up. To investigate these claims, two bi-coastal research groups are initiating major studies. In New York, researchers are looking at the effect of non-psychoactive cannabinoids over years. Additionally, at the University of California, San Diego team is studying cannabis’ neuronal and behavioral effects on children with autism.
Though parents of children with autism have long advocated for cannabis accessibility, this could be the first step in legitimating cannabinoid medication for autism.
According to the Autism Society of America, autism is “a complex developmental disability; signs typically appear during early childhood and affect a person’s ability to communicate.”
Autism is a ‘spectrum disorder’, meaning that its severity and symptoms can vary. These can include seizures, the complete inability to speak, anxiety and frustration.
There are numerous of anecdotal cases of cannabis functioning as a treatment for autism. Scott Badesch, President of the Autism Society of America, told High Times that they hear from a lot of parents who extol the virtues of marijuana for cannabis.
- Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Secures Funding for Clinical Trials - Medical Marijuana, Inc.www.medicalmarijuanainc.comNovember 8, 2016
- Medical Cannabis a Possible Treatment for Autism? - Terpenes and Testing Magazineterpenesandtesting.comApril 26, 2017
- MEDICAL CANNABIS RESEARCH ROUNDTABLE URGES FEDERAL INVESTMENT IN RESEARCH & CLINICAL TRIALSwww.cnbc.comMay 4, 2016
- CHOP's Study on Medical Marijuana and Autism | Marijuana Doctorswww.marijuanadoctors.comJanuary 10, 2018